Log in

goodpods headphones icon

To access all our features

Open the Goodpods app
Close icon
DCAT Value Chain Insights’ Production to Prescription - 2020 Vision: Digital Pharma—Beyond the Pill

2020 Vision: Digital Pharma—Beyond the Pill

06/29/20 • 10 min

DCAT Value Chain Insights’ Production to Prescription

In this podcast we feature an article that explores the future of digital medicines. For a text version of this article, visit dcatvci.org.

Key topics: (see Chapter Markers)

  • Digital medicines and digital health
  • Digital health and digital medicines: a market view
  • Pharma industry and digital health and digital medicines

Links:

Subscribe to our e-newsletter at www.dcatvci.org

Follow us on Twitter @DCATvci

Support the show

plus icon
bookmark

In this podcast we feature an article that explores the future of digital medicines. For a text version of this article, visit dcatvci.org.

Key topics: (see Chapter Markers)

  • Digital medicines and digital health
  • Digital health and digital medicines: a market view
  • Pharma industry and digital health and digital medicines

Links:

Subscribe to our e-newsletter at www.dcatvci.org

Follow us on Twitter @DCATvci

Support the show

Previous Episode

undefined - A Top 10 Emerging Pharma Watch List

A Top 10 Emerging Pharma Watch List

In this podcast we feature DCAT Value Chain Insights’ Top 10 Emerging Pharma Watch List based on recent high-value partnering deals. For a text version of this article visit dcatvci.org.

Key topics: (see Chapter Markers)

  • Emerging pharma strength
  • 1. Roivant Sciences
  • 2. Sangamo Therapeutics
  • 3. Silence Therapeutics
  • 4. Innovent Biologics
  • 5. Arcus Biosciences
  • 6. MorphoSys
  • 7. Evox Therapeutics
  • 8. Accent Therapeutics
  • 9. Enleofen Bio
  • 10. Sitryx

Links:

Subscribe to our e-newsletter at www.dcatvci.org

Follow us on Twitter @DCATvci

Support the show

Next Episode

undefined - Re-configuring Global Pharma Supply Chains

Re-configuring Global Pharma Supply Chains

In this podcast we feature an article that looks at the policy debate to repatriate and increase domestic drug manufacturing in the US in light of the COVID-19 pandemic and pharmaceutical supply-chain vulnerabilities. For a text version of this article visit dcatvci.org.

Key topics: (see Chapter Markers)

  • A plan for addressing supply-chain vulnerabilities in the US
  • Legislative proposals in the US

Links:

Subscribe to our e-newsletter at www.dcatvci.org

Follow us on Twitter @DCATvci

Support the show

Episode Comments

Generate a badge

Get a badge for your website that links back to this episode

Select type & size
Open dropdown icon
share badge image

<a href="https://goodpods.com/podcasts/dcat-value-chain-insights-production-to-prescription-649633/2020-vision-digital-pharmabeyond-the-pill-85679252"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to 2020 vision: digital pharma—beyond the pill on goodpods" style="width: 225px" /> </a>

Copy